Literature DB >> 21130733

Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions.

Yanfeng Zhang1, Garry W Buchko, Ling Qin, Howard Robinson, Susan M Varnum.   

Abstract

The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans. Two BoNT serotypes, C and D, while rarely associated with human infection, are responsible for deadly botulism outbreaks afflicting animals. Also associated with animal infections is the BoNT C-D mosaic protein (BoNT/CD), a BoNT subtype that is essentially a hybrid of the BoNT/C (∼two-third) and BoNT/D (∼one-third) serotypes. While the amino acid sequence of the heavy chain receptor binding (HCR) domain of BoNT/CD (BoNT/CD-HCR) is very similar to the corresponding amino acid sequence of BoNT/D, BoNT/CD-HCR binds synaptosome membranes better than BoNT/D-HCR. To obtain structural insights for the different membrane binding properties, the crystal structure of BoNT/CD-HCR (S867-E1280) was determined at 1.56 Å resolution and compared to previously reported structures for BoNT/D-HCR. Overall, the BoNT/CD-HCR structure is similar to the two sub-domain organization observed for other BoNT HCRs: an N-terminal jellyroll barrel motif and a C-terminal β-trefoil fold. Comparison of the structure of BoNT/CD-HCR with BoNT/D-HCR indicates that K1118 has a similar structural role as the equivalent residue, E1114, in BoNT/D-HCR, while K1136 has a structurally different role than the equivalent residue, G1132, in BoNT/D-HCR. Lysine-1118 forms a salt bridge with E1247 and may enhance membrane interactions by stabilizing the putative membrane binding loop (K1240-N1248). Lysine-1136 is observed on the surface of the protein. A sulfate ion bound to K1136 may mimic a natural interaction with the negatively changed phospholipid membrane surface. Liposome-binding experiments demonstrate that BoNT/CD-HCR binds phosphatidylethanolamine liposomes more tightly than BoNT/D-HCR. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21130733      PMCID: PMC3019264          DOI: 10.1016/j.bbrc.2010.11.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.

Authors:  Lilia K Koriazova; Mauricio Montal
Journal:  Nat Struct Biol       Date:  2003-01

2.  The most poisonous poison.

Authors:  C LAMANNA
Journal:  Science       Date:  1959-09-25       Impact factor: 47.728

3.  SuperPose: a simple server for sophisticated structural superposition.

Authors:  Rajarshi Maiti; Gary H Van Domselaar; Haiyan Zhang; David S Wishart
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

5.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 6.  Clostridium botulinum: a bug with beauty and weapon.

Authors:  H D Shukla; S K Sharma
Journal:  Crit Rev Microbiol       Date:  2005       Impact factor: 7.624

Review 7.  Transbilayer phospholipid movement and the clearance of apoptotic cells.

Authors:  Patrick Williamson; Robert A Schlegel
Journal:  Biochim Biophys Acta       Date:  2002-12-30

Review 8.  Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins.

Authors:  M D Collins; A K East
Journal:  J Appl Microbiol       Date:  1998-01       Impact factor: 3.772

9.  Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland.

Authors:  Miia Lindström; Mari Nevas; Joanna Kurki; Raija Sauna-aho; Annikki Latvala-Kiesilä; Ilpo Pölönen; Hannu Korkeala
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.

Authors:  G Schiavo; F Benfenati; B Poulain; O Rossetto; P Polverino de Laureto; B R DasGupta; C Montecucco
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

View more
  7 in total

1.  The receptor binding domain of botulinum neurotoxin serotype C binds phosphoinositides.

Authors:  Yanfeng Zhang; Susan M Varnum
Journal:  Biochimie       Date:  2011-11-18       Impact factor: 4.079

2.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of L-lactate dehydrogenase and its H171C mutant from Bacillus subtilis.

Authors:  Yanfeng Zhang; Xiaoli Gao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

3.  Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice.

Authors:  Jaeyoon Byun; Seongsung Kwak; Jin-Hee Kwon; Minhee Shin; Dong-Kyu Lee; Chang-Hoon Rhee; Won-Ho Kang; Jae-Wook Oh; Deu John M Cruz
Journal:  Toxins (Basel)       Date:  2022-05-25       Impact factor: 5.075

4.  Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.

Authors:  Yanfeng Zhang; Anna S Gardberg; Thomas E Edwards; Banumathi Sankaran; Howard Robinson; Susan M Varnum; Garry W Buchko
Journal:  Biochimie       Date:  2013-03-21       Impact factor: 4.079

5.  Crystal structures of botulinum neurotoxin DC in complex with its protein receptors synaptotagmin I and II.

Authors:  Ronnie Per-Arne Berntsson; Lisheng Peng; Linda Marie Svensson; Min Dong; Pål Stenmark
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

6.  Structural genomics of infectious disease drug targets: the SSGCID.

Authors:  Robin Stacy; Darren W Begley; Isabelle Phan; Bart L Staker; Wesley C Van Voorhis; Gabriele Varani; Garry W Buchko; Lance J Stewart; Peter J Myler
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-13

Review 7.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.